No profile data available.
Yarrow Bioscience, Inc. (YARW) is a listed company, based in New York, United States, with about 7 full-time employees.
Its market capitalization was $183.39 million as of October 9, 2026.
Figures from company filings and market data; market data as of October 9, 2026.
Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company's candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves' disease and thyroid eye disease.
$183.39 million as of October 9, 2026.